MedPath

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

Recruiting
Conditions
Telangiectasia, Hereditary Hemorrhagic
Registration Number
NCT00230620
Lead Sponsor
Imperial College London
Brief Summary

This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)

Detailed Description

Hereditary haemorrhagic telangiectasia (HHT) is a condition inherited as an autosomal dominant trait. Sequencing DNA from affected and unaffected family members allows us to identify disease-causal genes. Sequencing these genes allows us to identify what the precise DNA variants are which are causing disease, particularly if linked to functional assays in separate studies.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Member of family affected by HHT
Exclusion Criteria
  • Unable or unwilling to provide informed consent for DNA sample

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Imperial College Hammersmith Campus

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath